Shih-Hsiu “Jerry” Wang, MD, PhD, has been promoted to associate professor, effective Dec, 1st, 2024. He was awarded several grants to fund his studies on Alzheimer’s Disease and dementia. His work is focused on translational research in Alzheimer’s disease and related dementias (ADRD), specifically in delineating the pathogenic mechanisms linking AD and other common neurodegenerative and vascular pathologies. His current research focus is on limbic-predominant age-related TDP-43 encephalopathy (LATE), a common brain pathology that causes amnestic dementia in the elderly.
“We are delighted to celebrate Dr. Jerry Wang’s well-earned promotion,” said Neuropathology Division Chief Thomas J. Cummings, M.D. “Jerry is an accomplished clinical neuropathologist and translational science researcher, and he has a key role in the Duke-UNC Alzheimer’s Disease Research Center and Duke Institute for Brain Sciences to study neurodegenerative diseases. We are lucky to have him on our team!”
Wang obtained his MD from National Taiwan University and then completed his PhD in Neuroscience from Johns Hopkins University by studying the molecular mechanisms of synaptic refinement. Subsequently, he completed his training in anatomic pathology and neuropathology from New York Presbyterian Hospital/Columbia University Irving Medical Center. He joined Duke Pathology in 2018 and serves as the director of the Duke Bryan Brain Bank and Biorepository with active collaborations between the Departments of Neurology and Medicine.
In July 2024, Wang was awarded an Alzheimer’s Association Research Grant (AARG) for his proposal titled “Elucidating the Role of Vascular Dysfunction in LATE, LATE-AD, and FTLD-TDP.” He was recognized for his Alzheimer’s Disease research In October 2023, when he received an NC Biotechnology Center Grant for Collaborative Project on Alzheimer’s Disease.
Learn more about Shih-Hsiu Wang Lab’s research here